Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
project, funded by the Walloon Region as part of its Win4Excellence program. It aims to develop various disruptive technologies as solutions to major challenges in the gene therapy sector
-
vectors and which may contribute to the effectiveness of gene therapy. The Institute for Medical Immunology aims at delivering new concepts of immunointervention for human diseases by integrating basic and
-
part of the GT4Health project, funded by the Walloon Region as part of its Win4Excellence program. It aims to develop various disruptive technologies as solutions to major challenges in the gene therapy
-
phthalocyanines. These will be investigated for their photodynamic therapy activity and in photoelectrochemical sensing devices for cancer biomarkers. Position You prepare a doctoral thesis in the field of singlet
-
, Belgium) is looking for a highly motivated PhD student to unravel the cellular and molecular mechanisms underlying food reactivity and response to dietary and anti-inflammatory therapy in patients with
-
: “Plasma-treated hydrogels as a new selective therapy for head and neck cancer” ABOUT GHENT UNIVERSITY Ghent University is a world of its own. Employing more than 15.000 people, it is actively involved in
-
identify better who will benefit most from therapy and when. As a PhD candidate, you will chart the current management approaches in Belgium and Europe building a (inter)national NTM registry whilst
-
What? The TBM programme provides funding for biomedical research that focuses on new therapies or diagnoses, which are already further on the path from discovery to clinical application and offer a
-
, lethal, hard-to-cure brain tumor. Accumulating evidence points to extensive tumor heterogeneity, as well as plasticity in response to therapy, leading to therapy failure. At the single cell level, this
-
single-cell and spatial multi-omics datasets. The primary focus of this role is to delve deeper into the molecular mechanisms driving intra-tumor heterogeneity, plasticity, and therapy resistance